Back to Verition Fund Management LLC Verition Fund Management LLC

KNSAKNSA
6 quarters

Position history for Verition Fund Management LLCVerition Fund Management LLC's holdings in KINIKSA PHARMACEUTICALS INTL

Verition Fund Management LLC holds 7,500 shares of KNSA (KINIKSA PHARMACEUTICALS INTL), worth $479,625 as of 2026-Q2. This is a new position. KNSA represents 0.0% of Verition Fund Management LLC's portfolio.

Current Value

$479,625

Current Shares

7,500

Total Value Change

-$189,707

Total Shares Change

-19,284

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
7,500
-
$479,6250.0%$63.95
33
2025-Q3
Exited
0
-100.0%
$00.0%$38.77
0
2025-Q2
Decreased
21,368
-23.7%
$591,2530.0%$28.04
0
2025-Q1
Decreased
27,993
-48.9%
$621,7250.0%$23.09
0
2024-Q4
Increased
54,728
+104.3%
$1.1M0.0%$19.60
41
2024-Q3
New
26,784
-
$669,3320.0%$25.00
34

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used